Market Research Logo

Smoking Cessation And Nicotine De-addiction Market Analysis By Product (Nicotine Replacement Therapy, Inhalers, Gums, Patches, Lozenges, Sprays, Sublingual Tablets, Varenicline, Bupropione, Drug therapy, E-cigarettes) And Segment Forecasts To 2024

Smoking Cessation And Nicotine De-addiction Market Analysis By Product (Nicotine Replacement Therapy, Inhalers, Gums, Patches, Lozenges, Sprays, Sublingual Tablets, Varenicline, Bupropione, Drug therapy, E-cigarettes) And Segment Forecasts To 2024

The global smoking cessation and nicotine de-addiction market is expected to reach over USD 21.8 billion by 2024 according to a new report by Grand View Research, Inc.

The base of population addicted to smoking is rapidly increasing across the globe. This population subset majorly includes teenagers and the working population. Smoking-related mortality is very high. The increasing desire to quit smoking and the numerous health complications associated with smoking serve as strong incentives for companies to introduce novel smoking cessation products, such as Revolymer, which has introduced the next generation nicotine gums to help smokers quit smoking. The launch of these improved and innovative nicotine replacement therapy products is to serve as a high impact rendering driver for the growth of the smoking cessation and nicotine de-addiction market.

The growing incidence of target diseases such as chronic obstructive pulmonary disease (COPD), asthma, cardiac diseases, and lung cancer, and the increasing awareness pertaining to the hazardous side-effects of smoking are the factors expected to promote market expansion. Educational institutions remain active in organizing various campaigns and programs to spread information about the harmful effects and consequences of smoking so as to increase young population awareness.

Further key findings from the study suggest:

Nicotine Replacement Therapy (NRT) dominated the smoking cessation and de-nicotine addiction product market in 2015. Majorly used NRT products include nicotine chewing gums and the transdermal patches. Increased availability and the introduction of the ingestible nicotine products with different flavors are the factors responsible for its large market share.

The e-cigarette segment is anticipated to grow at a CAGR of19.0% over the forecast period. The major factors responsible for the growth of the E-cigarette market include the introduction of second and third generation e-cigarettes, the availability of various flavored products, the presence of numerous vendors operating and selling e-cigarettes under different brand names.

North America held a large market share of over 35.0% in 2015 owing to the high awareness levels of nicotine de-addiction products with around 90% of the U.S. population were identified as aware of e-cigarettes in 2015

Asia Pacific is the fastest growing market. The registration of nicotine de-addiction products and e-cigarettes as well as the strengthening of the company distribution channels in countries, such as China, India, and Australia are expected to support the growth over the forecast period

Some key players of this market are Pfizer, Inc., Cipla Ltd., Novartis International AG, GlaxoSmithKline plc, Takeda pharmaceutical Company Ltd., McNeil AB, Revolymer plc, Imperial Tobacco Ltd., and VMR products, LLC

The market players are making slow but steady progress in the e-cigarette market by focusing on the development, commercialization, and distribution of the FDA approved nicotine products. For instance, in 2014, Victory Electronic Cigarettes Corporation acquired Ten Motives Ltd. with an aim to expand their distribution channels and attain wider market coverage.


Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Smoking Cessation and Nicotine De-addiction Market- Industry Snapshot and Key Buying Criteria, 2015
Chapter 3. Smoking Cessation and Nicotine De-addiction Industry Outlook
3.1. Smoking Cessation and Nicotine De-addiction Market Segmentation
3.2. Smoking Cessation and Nicotine De-addiction Market Size and Growth Prospects
3.3. Smoking Cessation and Nicotine De-addiction Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Increasing demand for Nicotine De-addiction products
3.3.1.2. General awareness regarding the associated side-effects of smoking
3.3.1.3. Launch of new Nicotine De-addiction products
3.3.2. Market Restraint Analysis
3.4. Industry Analysis - Porter's
3.5. Smoking Cessation and Nicotine De-addiction Market PESTEL Analysis, 2015
Chapter 4. Smoking Cessation and Nicotine De-addiction Product Outlook
4.1. Smoking Cessation and Nicotine De-addiction Market Share By Product, 2015& 2024
4.2. Nicotine Replacement Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.1. Nicotine Sprays Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.2. Nicotine Inhalers Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.3. Nicotine Gums Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.4. Nicotine Transdermal Patches Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.5. Nicotine Sublingual Tablets Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.2.6. Nicotine Lozenges Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.3. Drug Therapy Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.3.1. Varenicline Oral Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.3.2. Zyban Oral Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.3.3. Nicorette Buccal Market Estimates and Forecasts, 2013 - 2024 (USD Million)
4.4. E-cigarettes/ E-liquid Market Estimates and Forecasts, 2013 - 2024 (USD Million)
Chapter 5. Smoking Cessation and Nicotine De-addiction Regional Outlook
5.1. Smoking Cessation and Nicotine De-addiction Market Share By Region, 2015 -2024
5.2. North America
5.2.1. North America Market Estimates and Forecasts, by Product, 2013 - 2024 (USD Million)
5.2.1.1. U.S. Market Estimates and Forecasts
5.2.1.2. Canada Market Estimates and Forecasts
5.3. Europe
5.3.1. Europe Market Estimates and Forecasts, by Product, 2013 - 2024 (USD Million)
5.3.1.1. Germany Market Estimates and Forecasts
5.3.1.2. UK Market Estimates and Forecasts
5.4. Asia Pacific
5.4.1. Asia Pacific Market Estimates and Forecasts, by Product, 2013 - 2024 (USD Million)
5.4.1.1. Japan Market Estimates and Forecasts
5.4.1.2. China Market Estimates and Forecasts
5.5. Latin America
5.5.1. Latin America Market Estimates and Forecasts, by Product, 2013 - 2024 (USD Million)
5.5.1.1. Brazil Market Estimates and Forecasts
5.6. MEA
5.6.1. MEA Market Estimates and Forecasts, by Product, 2013 - 2024 (USD Million)
5.6.1.1. South Africa Market Estimates and Forecasts
Chapter 6. Competitive Landscape
6.1. Pfizer, Inc.
6.1.1. Company Overview
6.1.2. Financial Performance
6.1.3. Product Benchmarking
6.1.4. Strategic Initiatives
6.2. GSK plc
6.2.1. Company Overview
6.2.2. Financial Performance
6.2.3. Product Benchmarking
6.2.4. Strategic Initiatives
6.3. Cipla Ltd.
6.3.1. Company Overview
6.3.2. Financial Performance
6.3.3. Product Benchmarking
6.3.4. Strategic Initiatives
6.4. Novartis International AG
6.4.1. Company Overview
6.4.2. Financial Performance
6.4.3. Product Benchmarking
6.4.4. Strategic Initiatives
6.5. McNeil AB
6.5.1. Company Overview
6.5.2. Financial Performance
6.5.3. Product Benchmarking
6.5.4. Strategic Initiatives
6.6. Revolymer plc
6.6.1. Company Overview
6.6.2. Financial Performance
6.6.3. Product Benchmarking
6.6.4. Strategic Initiatives
6.7. Takeda Pharmaceutical Company Ltd.
6.7.1. Company Overview
6.7.2. Financial Performance
6.7.3. Product Benchmarking
6.7.4. Strategic Initiatives
6.8. Imperial Tobacco Ltd.
6.8.1. Company Overview
6.8.2. Financial Performance
6.8.3. Product Benchmarking
6.8.4. Strategic Initiatives
6.9. VMR products, LLC
6.9.1. Company Overview
6.9.2. Financial Performance
6.9.3. Product Benchmarking
6.9.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report